BIT biotron limited
Add to My Watchlist 20.0% ! 0.2¢

hepdart paper - data analysis, page-3

  1. J8
    14,774 Posts.
    lightbulb Created with Sketch. 863
    clock Created with Sketch.
    03/01/12
    12:16
    Post #: 9504222
    Old mac , The HIV study is even smaller so there will be no outstanding results only a good guide just like the HCV trial .


    Your test , however statistically accurate does not hide the fact that the trial was an outstanding success . No other drug has done what this has .
    BIT Price at posting: 13.0¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 3  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS Access the latest ASX news here
right-arrow Created with Sketch.
NEWS AnteoTech and Black Diamond Structures to Progress Advanced Battery Product in the USA
right-arrow Created with Sketch.
NEWS Cangallo drilling returns wide copper intercepts
right-arrow Created with Sketch.
NEWS Peregrine Gold discovers high grade channel iron deposit at Newman gold project, WA
right-arrow Created with Sketch.
NEWS The Japan Organization for Metals and Energy Security joins the Speewah fluorite project
right-arrow Created with Sketch.
NEWS Nyrada completes final dosing in Xolatryp Phase I clinical trial
right-arrow Created with Sketch.
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist
(20min delay)
Last
0.2¢ 		Change
-0.001(20.0%) 		Mkt cap ! $2.654M
Open High Low Value Volume
0.2¢ 0.2¢ 0.2¢ $20 10K

Buyers (Bids)

No. Vol. Price($)
45 30477207 0.2¢
 

Sellers (Offers)

Price($) Vol. No.
0.3¢ 15991079 21
View Market Depth
Last trade - 12.28pm 23/07/2025 (20 minute delay) ?
BIT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.